Press

Tanvex CDMO to Exhibit at the 15th Annual World ADC Conference in San Diego

Read More 

›

Tanvex Appoints Biopharma Industry Veteran Stephen Lam as CEO

Read More 

›

Tanvex BioPharma Forging Strategic Alliance with Bora Pharmaceuticals

Read More 

›

Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi™ and FDA Accepts Biosimilar Biologics License Application for TX-05

Read More 

›

Tanvex CDMO Launch Empowers Advancements in Novel Biologics and Biosimilars

Read More 

›

Categories

Subscribe to our Newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.